Content about National Cancer Institute

February 10, 2014

Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health.

ROCKVILLE, Md. — Women who take aspirin daily may reduce their risk of ovarian cancer by 20%, according to a study by scientists at the National Cancer Institute, part of the National Institutes of Health. 

The study was published Feb. 6 in the Journal of the National Cancer Institute.

December 19, 2013

Diplomat has become a distributor of a new cancer drug made by Genentech, Diplomat said Thursday.

FLINT, Mich. — Diplomat has become a distributor of a new cancer drug made by Genentech, Diplomat said Thursday.

The specialty pharmacy company said it had received a distribution contract for Gazyva (obinutuzumab) for chronic lymphocytic leukemia, which received Food and Drug Administration approval on Nov. 1. CLL is a slowly advancing blood and bone marrow disease that, according to the National Cancer Institute, part of the National Institutes of Health, will be diagnosed in 15,680 Americans this year and cause 4,580 deaths.

September 20, 2013

The Centers for Disease Control and Prevention's 2013 Tips From Former Smokers campaign produced more than 150,000 additional calls to 1-800-QUIT-NOW, a number that links callers to their state quitlines, according to a report in last week's Morbidity and Mortality Weekly Report.

ATLANTA — The Centers for Disease Control and Prevention's 2013 Tips From Former Smokers campaign produced more than 150,000 additional calls to 1-800-QUIT-NOW, a number that links callers to their state quitlines, according to a report in this week's Morbidity and Mortality Weekly Report. The campaign also generated almost 2.8 million additional visitors to the campaign website, cdc.gov/tips.

August 19, 2013

The limitations within a recent study linking omega-3 fish oil and increased prostate cancer risk ought to be taken in consideration, according to a commentary published in the August issue of Natural Medicine Journal.

WASHINGTON — The limitations within a recent study linking omega-3 fish oil and increased prostate cancer risk ought to be taken in consideration, according to a commentary published in the August issue of Natural Medicine Journal

July 12, 2013

A second large, prospective study by scientists at Fred Hutchinson Cancer Research Center that claimed to confirm the link between high blood concentrations of omega-3 fatty acids and an increased risk of prostate cancer drew a stark industry response from supplement trade associations.

SEATTLE — A second large, prospective study by scientists at Fred Hutchinson Cancer Research Center released on Wednesday that claimed to confirm the link between high blood concentrations of omega-3 fatty acids and an increased risk of prostate cancer drew a stark industry response from supplement trade associations.

February 5, 2013

A JAMA report released suggested a high intake of supplemental calcium is associated with an increased risk of cardiovascular disease death in men was criticized by several dietary supplement agencies for being inconclusive.

CHICAGO — A JAMA report released Monday afternoon that suggested a high intake of supplemental calcium is associated with an increased risk of cardiovascular disease death in men was criticized by several dietary supplement agencies for being inconclusive. According to the Council for Responsible Nutrition's most recent survey of U.S. adults, 17% indicated they take a calcium supplement.

August 13, 2012

A large new observational study published Friday found more evidence of an association between daily aspirin use and modestly lower cancer mortality, but suggested any reduction may be smaller than that observed in a recent analysis. The study appeared online in the Journal of the National Cancer Institute.

ATLANTA — A large new observational study published Friday found more evidence of an association between daily aspirin use and modestly lower cancer mortality, but suggested any reduction may be smaller than that observed in a recent analysis. The study appeared online in the Journal of the National Cancer Institute.

August 9, 2012

The Food and Drug Administration has approved a new drug for treating a rare type of leukemia, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare type of leukemia, the agency said Thursday.

The FDA approved South San Francisco, Calif.-based Talon Therapeutics' Marqibo (vincristine sulfate liposome), an injectable drug for Philadelphia chromosome-negative acute lymphoblasic leukemia, or Ph-negative ALL.

March 30, 2012

Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

ATLANTA — Mortality rates from all cancers combined continued to drop between 2004 and 2008 among men, women and children, according to the annual "Report to the Nation on the Status of Cancer, 1975-2008."

September 1, 2011

A new report from the National Center for Health Statistics, which is part of the Centers for Disease Control and Prevention, sheds light on sugar drink consumption habits among the U.S. population.

WASHINGTON — A new report from the National Center for Health Statistics, which is part of the Centers for Disease Control and Prevention, sheds light on sugar drink consumption habits among the U.S. population.

August 30, 2011

A new study that is slated to appear in the October issue of the American Journal of Preventive Medicine found that postmenopausal women may improve their insulin sensitivity through such interventions as diet, exercise, or a combination of the two.

NEW YORK — A new study that is slated to appear in the October issue of the American Journal of Preventive Medicine found that postmenopausal women may improve their insulin sensitivity through such interventions as diet, exercise, or a combination of the two.

May 18, 2011

Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

ORLANDO, Fla. — Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

The overall drug trend for 2010 was 3.7%, lowered by higher rates of generic drug dispensing; more than 71% of drugs dispensed were generics. Specialty drugs, mostly branded biologics, accounted for 70.1% of the overall drug trend, with especially strong growth in cancer drugs, whose drug trend reached 21.2%.